Operating Income (Loss) in USD of WINDTREE THERAPEUTICS INC /DE/ from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
WINDTREE THERAPEUTICS INC /DE/ quarterly/annual Operating Income (Loss) history and change rate from Q2 2010 to Q3 2025.
  • WINDTREE THERAPEUTICS INC /DE/ Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$19.9M, a 319% decline year-over-year.
  • WINDTREE THERAPEUTICS INC /DE/ Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$33.5M, a 31.1% decline year-over-year.
  • WINDTREE THERAPEUTICS INC /DE/ annual Operating Income (Loss) for 2024 was -$26.1M, a 26.9% decline from 2023.
  • WINDTREE THERAPEUTICS INC /DE/ annual Operating Income (Loss) for 2023 was -$20.6M, a 50.2% increase from 2022.
  • WINDTREE THERAPEUTICS INC /DE/ annual Operating Income (Loss) for 2022 was -$41.3M, a 46.5% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

WINDTREE THERAPEUTICS INC /DE/ Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$33.5M -$19.9M -$15.1M -319% 01 Jul 2025 30 Sep 2025 10-Q 19 Nov 2025
Q2 2025 -$18.4M -$3.98M +$7.47M +65.2% 01 Apr 2025 30 Jun 2025 10-Q 19 Aug 2025
Q1 2025 -$25.8M -$4.09M +$315K +7.15% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 -$26.1M -$5.54M -$582K -11.7% 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025
Q3 2024 -$25.6M -$4.74M -$51K -1.09% 01 Jul 2024 30 Sep 2024 10-Q 19 Nov 2025
Q2 2024 -$25.5M -$11.5M -$4.7M -69.5% 01 Apr 2024 30 Jun 2024 10-Q 19 Aug 2025
Q1 2024 -$20.8M -$4.41M -$214K -5.11% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 -$20.6M -$4.96M +$5.85M +54.1% 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 -$26.5M -$4.69M -$40K -0.86% 01 Jul 2023 30 Sep 2023 10-Q 26 Nov 2024
Q2 2023 -$26.4M -$6.76M +$10.8M +61.5% 01 Apr 2023 30 Jun 2023 10-Q 19 Aug 2024
Q1 2023 -$37.2M -$4.19M +$4.14M +49.7% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 -$41.3M -$10.8M +$3.88M +26.4% 01 Oct 2022 31 Dec 2022 10-K 16 Apr 2024
Q3 2022 -$45.2M -$4.65M +$3.5M +42.9% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$48.7M -$17.5M +$27.8M +61.3% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023
Q1 2022 -$76.5M -$8.33M +$746K +8.22% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$77.3M -$14.7M -$7.73M -111% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 -$69.5M -$8.15M +$558K +6.41% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$70.1M -$45.4M -$37.4M -471% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 -$32.7M -$9.08M -$2.38M -35.4% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q4 2020 -$30.3M -$6.96M -$2.41M -52.9% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 -$27.9M -$8.71M -$1.52M -21.1% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$26.4M -$7.95M -$1.45M -22.4% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021
Q1 2020 -$24.9M -$6.7M -$46K -0.69% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 -$24.9M -$4.55M +$297K +6.12% 01 Oct 2019 31 Dec 2019 10-K 03 Apr 2020
Q3 2019 -$25.2M -$7.19M -$3.72M -107% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020
Q2 2019 -$21.5M -$6.5M -$3.46M -114% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020
Q1 2019 -$18M -$6.66M -$1.82M -37.5% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020
Q4 2018 -$16.2M -$4.85M -$1.35M -38.7% 01 Oct 2018 31 Dec 2018 10-K 03 Apr 2020
Q3 2018 -$14.8M -$3.47M +$1.33M +27.7% 01 Jul 2018 30 Sep 2018 10-K 03 Apr 2020
Q2 2018 -$16.2M -$3.04M +$3.1M +50.6% 01 Apr 2018 30 Jun 2018 10-K 03 Apr 2020
Q1 2018 -$19.3M -$4.84M +$3.28M +40.4% 01 Jan 2018 31 Mar 2018 10-K 03 Apr 2020
Q4 2017 -$22.5M -$3.5M +$2.87M +45.1% 01 Oct 2017 31 Dec 2017 10-K/A 23 Apr 2019
Q3 2017 -$25.4M -$4.79M +$2.94M +38% 01 Jul 2017 30 Sep 2017 10-K/A 23 Apr 2019
Q2 2017 -$28.4M -$6.14M +$3.85M +38.6% 01 Apr 2017 30 Jun 2017 10-K/A 23 Apr 2019
Q1 2017 -$32.2M -$8.12M +$5.83M +41.8% 01 Jan 2017 31 Mar 2017 10-K/A 23 Apr 2019
Q4 2016 -$38M -$6.37M +$3.41M +34.9% 01 Oct 2016 31 Dec 2016 10-K 17 Apr 2018
Q3 2016 -$41.4M -$7.73M +$710K +8.41% 01 Jul 2016 30 Sep 2016 10-K 17 Apr 2018
Q2 2016 -$42.2M -$9.99M +$444K +4.25% 01 Apr 2016 30 Jun 2016 10-K 17 Apr 2018
Q1 2016 -$42.6M -$13.9M -$2.77M -24.8% 01 Jan 2016 31 Mar 2016 10-K 17 Apr 2018
Q4 2015 -$39.8M -$9.78M +$1.45M +12.9% 01 Oct 2015 31 Dec 2015 10-K 31 Mar 2017
Q3 2015 -$41.3M -$8.44M +$1.88M +18.2% 01 Jul 2015 30 Sep 2015 10-K 31 Mar 2017
Q2 2015 -$43.2M -$10.4M +$505K +4.62% 01 Apr 2015 30 Jun 2015 10-K 31 Mar 2017
Q1 2015 -$43.7M -$11.2M -$410K -3.81% 01 Jan 2015 31 Mar 2015 10-K 31 Mar 2017
Q4 2014 -$43.3M -$11.2M -$961K -9.36% 01 Oct 2014 31 Dec 2014 10-K 29 Mar 2016
Q3 2014 -$42.3M -$10.3M +$486K +4.5% 01 Jul 2014 30 Sep 2014 10-K 29 Mar 2016
Q2 2014 -$42.8M -$10.9M -$132K -1.22% 01 Apr 2014 30 Jun 2014 10-K 29 Mar 2016
Q1 2014 -$42.7M -$10.8M +$1.86M +14.7% 01 Jan 2014 31 Mar 2014 10-K 29 Mar 2016
Q4 2013 -$44.5M -$10.3M +$2.16M +17.4% 01 Oct 2013 31 Dec 2013 10-K 16 Mar 2015
Q3 2013 -$46.7M -$10.8M -$815K -8.15% 01 Jul 2013 30 Sep 2013 10-K 16 Mar 2015
Q2 2013 -$45.9M -$10.8M -$1.99M -22.6% 01 Apr 2013 30 Jun 2013 10-K 16 Mar 2015
Q1 2013 -$43.9M -$12.6M -$6.04M -91.8% 01 Jan 2013 31 Mar 2013 10-K 16 Mar 2015
Q4 2012 -$37.8M -$12.4M -$6.52M -110% 01 Oct 2012 31 Dec 2012 10-K 17 Mar 2014
Q3 2012 -$31.3M -$10M -$3.83M -62% 01 Jul 2012 30 Sep 2012 10-K 17 Mar 2014
Q2 2012 -$27.5M -$8.82M -$2.44M -38.2% 01 Apr 2012 30 Jun 2012 10-K 17 Mar 2014
Q1 2012 -$25M -$6.58M -$521K -8.6% 01 Jan 2012 31 Mar 2012 10-K 17 Mar 2014
Q4 2011 -$24.5M -$5.9M 01 Oct 2011 31 Dec 2011 10-K 15 Mar 2013
Q3 2011 -$6.17M +$33K +0.53% 01 Jul 2011 30 Sep 2011 10-K 15 Mar 2013
Q2 2011 -$6.38M -$152K -2.44% 01 Apr 2011 30 Jun 2011 10-K 15 Mar 2013
Q1 2011 -$6.06M 01 Jan 2011 31 Mar 2011 10-K 15 Mar 2013
Q3 2010 -$6.2M 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011
Q2 2010 -$6.23M 01 Apr 2010 30 Jun 2010 10-Q 15 Aug 2011

WINDTREE THERAPEUTICS INC /DE/ Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$26.1M -$5.54M -26.9% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025
2023 -$20.6M +$20.7M +50.2% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025
2022 -$41.3M +$35.9M +46.5% 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024
2021 -$77.3M -$47M -155% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 -$30.3M -$5.42M -21.8% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 -$24.9M -$8.7M -53.7% 01 Jan 2019 31 Dec 2019 10-K 29 Mar 2021
2018 -$16.2M +$6.35M +28.2% 01 Jan 2018 31 Dec 2018 10-K 03 Apr 2020
2017 -$22.5M +$15.5M +40.7% 01 Jan 2017 31 Dec 2017 10-K/A 23 Apr 2019
2016 -$38M +$1.8M +4.51% 01 Jan 2016 31 Dec 2016 10-K 17 Apr 2018
2015 -$39.8M +$3.42M +7.92% 01 Jan 2015 31 Dec 2015 10-K 31 Mar 2017
2014 -$43.3M +$1.25M +2.81% 01 Jan 2014 31 Dec 2014 10-K 29 Mar 2016
2013 -$44.5M -$6.69M -17.7% 01 Jan 2013 31 Dec 2013 10-K 16 Mar 2015
2012 -$37.8M -$13.3M -54.3% 01 Jan 2012 31 Dec 2012 10-K 16 Mar 2015
2011 -$24.5M +$1.02M +3.98% 01 Jan 2011 31 Dec 2011 10-K 17 Mar 2014
2010 -$25.5M 01 Jan 2010 31 Dec 2010 10-K 15 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.